TrialMedical oncology (Northwood, London, England)2015
Phase II dose-finding study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy.
Oleg Gladkov et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it